Question 2 Which medications effectively reduce pubertal gynaecomastia?
Abstract
Tom is a 12-year-old boy who presents with a 6-month history of breast enlargement. He is extremely embarrassed about the size of his breasts and avoids sport because he does not want to be seen while getting changed. He wonders if anything can be done to reduce the size of his breasts. Tom has Tanner stage III breast development. He has entered puberty and his height and weight are both on the 99th centile. He has a male karyotype and his hormone levels are all within the normal range. As Tom is so distressed, you decide that something needs to be done. You have heard that anti-oestrogens, such as tamoxifen, and aromatase inhibitors, such as anastrozole, can be used to treat pubertal gynaecomastia. You start Tom on 10 mg of tamoxifen daily, but after 6 months of treatment this has made little difference to the size of his breasts. You wonder whether anastrozole would be a more effective therapy. In boys with pubertal gynaecomastia [patient], is anastrozole [treatment] or tamoxifen [treatment] effective in reducing breast tissue [outcome] and which is more effective [comparison]? Details of relevant papers are summarised in table 2. View this table: Table 2 Which medications effectively reduce pubertal gynaecomastia? ### Primary sources The primary source was PubMed, using the search …
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In an earlier study a combination of spironolactone and testolactone proved effective.
“In an earlier study a combination of spironolactone and testolactone proved effective [56], whereas in later studies the combination of bicalutamide and anastrozole was used [57-59].”
From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [56]
Cites
Plourde, P. V., Reiter, E. O., Jou, H.-C., Desrochers, P. E., Rubin, S. D., Bercu, B. B., Diamond, F. B., Backeljauw, P. F., & Study, M. O. T. A. G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0082 · Cited by 128 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Aromatase inhibitors in men: effects and therapeutic options
de Ronde, W., & de Jong, F. H. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-93 · Cited by 155 · see citing works
- Authors
- Maidment, S. L.
- Affiliations
- Peterborough City Hospital (GB)
- Corresponding author
- Maidment, S. L
- Venue
- Archives of Disease in Childhood
- Publisher
- BMJ
- Published
- 2010-03-01
- Volume
- 95
- Issue
- 3
- Pages
- 237-239
- ISSN
- 0003-9888 (ISSN-L)
- 1468-2044
- OpenAlex
- W2146397488
- Cited by
- 11
- References
- 1
- Citations by year
- 2022: 1 · 2018: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Disease in Childhood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Male Breast Health Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Keywords
- anastrozole, tamoxifen, antiestrogens, aromatase inhibitors, puberty, treatment efficacy
- MeSH terms
- Anastrozole, Child, Estrogen Antagonists, Gynecomastia, Humans, Male, Nitriles, Puberty, Tamoxifen, Triazoles, Treatment Outcome, Evidence-Based Medicine, Aromatase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review